|
Quotes & Info
|
| PEX > SEC Filings for PEX > Form 8-K on 5-Mar-2009 | All Recent SEC Filings |
5-Mar-2009
Other Events, Financial Statements and Exhibits
On March 4, 2009, the board of directors of Apex Bioventures Acquisition Corporation (the "Company") announced that it has determined that the Company will not consummate a business combination in the time frame required by its Second Amended and Restated Certificate of Incorporation, and that it is advisable that the Company be dissolved. The Company will not proceed to liquidate until a plan of liquidation is approved by the Company and its stockholders.
The Company will file a separate press release announcing the date of the stockholders meeting at which the board will seek stockholder approval and the record date for such meeting.
(c) Exhibits
99.1 Press release March 5, 2009
SIGNATURES
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 5, 2009 By: /s/ Darrell J. Elliott Darrell J. Elliott Chairman and Chief Executive Officer
|
|